These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31491041)

  • 1. Mutation profile of high-grade appendiceal mucinous neoplasm.
    Liao X; Vavinskaya V; Sun K; Hao Y; Li X; Valasek M; Xu R; Polydorides AD; Houldsworth J; Harpaz N
    Histopathology; 2020 Feb; 76(3):461-469. PubMed ID: 31491041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
    Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P
    Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
    Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms.
    Nishikawa G; Sekine S; Ogawa R; Matsubara A; Mori T; Taniguchi H; Kushima R; Hiraoka N; Tsuta K; Tsuda H; Kanai Y
    Br J Cancer; 2013 Mar; 108(4):951-8. PubMed ID: 23403822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.
    Raghav K; Shen JP; Jácome AA; Guerra JL; Scally CP; Taggart MW; Foo WC; Matamoros A; Shaw KR; Fournier K; Overman MJ; Eng C
    Br J Cancer; 2020 Oct; 123(8):1262-1270. PubMed ID: 32733093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience.
    Munari G; Businello G; Mattiolo P; Pennelli G; Sbaraglia M; Borga C; Pucciarelli S; Spolverato G; Mescoli C; Galuppini F; Sommariva A; Bellan E; Lonardi S; Loupakis F; Luchini C; Dei Tos AP; Fassan M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1897-1904. PubMed ID: 33712927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.
    Misdraji J; Yantiss RK; Graeme-Cook FM; Balis UJ; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1089-103. PubMed ID: 12883241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of molecular and morphological features of appendiceal epithelial neoplasms.
    Tsai JH; Yang CY; Yuan RH; Jeng YM
    Histopathology; 2019 Oct; 75(4):468-477. PubMed ID: 31111538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological spectrums and prognosis of primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and low-grade appendiceal mucinous neoplasms.
    Chen I; Liu X; Kovar-Peltz S; Conrad SJ; Chen HH; Liao X
    Pathology; 2023 Apr; 55(3):375-382. PubMed ID: 36454563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
    Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
    Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
    J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
    Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
    Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular targets in vulvar cancers.
    Palisoul ML; Mullen MM; Feldman R; Thaker PH
    Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants.
    LaFramboise WA; Pai RK; Petrosko P; Belsky MA; Dhir A; Howard PG; Becich MJ; Holtzman MP; Ahrendt SA; Pingpank JF; Zeh HJ; Dhir R; Bartlett DL; Choudry HA
    Mod Pathol; 2019 Jul; 32(8):1197-1209. PubMed ID: 30962504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.